🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/09/2013 11,05 11,08 10,81 10,92 -0,73% 2,44% 935.200
23/09/2013 10,95 11,07 10,75 11,00 -0,54% 2,92% 1.063.100
20/09/2013 10,77 11,11 10,42 11,06 +2,50% 6,41% 3.003.600
19/09/2013 10,76 10,94 10,57 10,79 +0,65% 3,44% 1.341.100
18/09/2013 10,62 10,82 10,53 10,72 +1,13% 2,73% 1.305.800
17/09/2013 10,70 10,72 10,49 10,60 -1,30% 2,15% 1.154.500
16/09/2013 10,71 10,94 10,52 10,74 +0,94% 3,92% 1.118.100
13/09/2013 11,13 11,21 10,52 10,64 -4,57% 6,20% 2.523.500
12/09/2013 11,57 11,62 11,14 11,15 -3,63% 4,15% 1.793.200
11/09/2013 11,70 11,88 11,51 11,57 -1,45% 3,16% 1.783.200
10/09/2013 12,05 12,17 11,31 11,74 -29,70% 7,14% 8.951.100
09/09/2013 16,15 16,74 16,15 16,70 +3,66% 3,65% 1.980.600
06/09/2013 16,60 16,62 16,03 16,11 -2,72% 3,55% 845.900
05/09/2013 16,48 16,63 16,23 16,56 +0,55% 2,43% 872.000
04/09/2013 15,71 16,51 15,60 16,47 +5,31% 5,79% 1.089.100
03/09/2013 14,85 16,01 14,62 15,64 +7,34% 9,36% 1.437.400
30/08/2013 14,95 15,12 14,47 14,57 -2,74% 4,35% 690.400
29/08/2013 15,03 15,07 14,69 14,98 +4,03% 2,53% 1.176.800
28/08/2013 14,40 14,60 14,25 14,40 -0,28% 2,43% 398.100
27/08/2013 15,11 15,43 14,44 14,44 -5,56% 6,55% 533.300
26/08/2013 15,03 15,65 14,97 15,29 +1,93% 4,52% 400.700
23/08/2013 15,00 15,12 14,92 15,00 +0,00% 1,33% 531.400
22/08/2013 15,00 15,08 14,85 15,00 +0,13% 1,53% 470.300
21/08/2013 14,93 15,33 14,80 14,98 +3,45% 3,55% 1.196.100
20/08/2013 14,19 14,52 14,13 14,48 +2,40% 2,75% 319.700
19/08/2013 14,43 14,66 14,14 14,14 -1,87% 3,60% 637.800
16/08/2013 14,42 14,61 14,26 14,41 +0,07% 2,43% 652.400
15/08/2013 14,43 14,50 14,10 14,40 -1,37% 2,77% 649.000
14/08/2013 14,70 14,85 14,58 14,60 -0,61% 1,84% 290.300
13/08/2013 14,25 14,69 14,25 14,69 +3,09% 3,09% 718.400